Gannet Biochem

Gannet BioChem is a biotechnology company based in Huntsville, Alabama, specializing as a contract development and manufacturing organization (CDMO) focused on the production of polyethylene glycol (PEG) reagents and other biopharmaceutical and therapeutic products. The company operates an FDA-inspected, GMP-compliant facility, providing end-to-end services from raw material sourcing to manufacturing and packaging for clinical and commercial therapeutics. Gannet BioChem was established following Ampersand Capital Partners’ acquisition of Nektar Therapeutics’ PEG reagent manufacturing business in December 2024, and is now owned by Ampersand. The company is led by CEO Nicholas Shackley and a newly expanded executive team, and leverages over 30 years of expertise in PEG chemistry to serve the biopharma industry. Revenue is generated through manufacturing, scaling, and supplying specialty PEG reagents and related services to pharmaceutical and biotech clients.

Recent Posts by Gannet Biochem

1-6 of 6